← Back to Browse

MediPal Holdings Corporation

MEPDF • Healthcare

66
Grade B
Compass
Current Price
$18.35
Market Cap
$531.1B

About MediPal Holdings Corporation

Medipal Holdings Corporation engages in the prescription pharmaceutical wholesale business in Japan. It procures healthcare products related to diagnostics, testing, treatment, and administration comprises medical equipment and medical materials, and clinical diagnostic reagents for use from the pre-symptomatic stage; handles PMS services on contract for manufacturers; and invests in orphan drugs and other products. The company is also involved in the wholesale of cosmetics, daily necessities, a

Quality Assessment

MediPal Holdings Corporation is a above-average quality healthcare company with a Compass Score of 66. This stock shows solid fundamentals with room for improvement in some areas. Worth considering for a diversified portfolio.

Score Breakdown

The Compass Score is based on 6 quality factors identified by academic research.

Click any factor to see detailed metrics

Valuation Metrics

Click any metric for details

Technical Overview

Click any metric for details

Growth Projections

Projected EPS Growth
๐Ÿ”’
Projected Revenue Growth
๐Ÿ”’

Financial Health

Click any metric for details

Important Disclaimer

The Compass Score is for educational purposes only and does not constitute financial advice. Past performance does not guarantee future results. Always do your own research and consider consulting a financial advisor before making investment decisions.